SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 132 filers reported holding SERES THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114 | -42.7% | 48,095 | +15.7% | 0.01% | -43.8% |
| Q2 2023 | $199 | +158.4% | 41,581 | +206.1% | 0.02% | +166.7% |
| Q1 2023 | $77 | -17.2% | 13,585 | -18.5% | 0.01% | -25.0% |
| Q4 2022 | $93 | -99.9% | 16,667 | +18.5% | 0.01% | 0.0% |
| Q3 2022 | $90,000 | -15.1% | 14,070 | -5.4% | 0.01% | +166.7% |
| Q1 2022 | $106,000 | +19.1% | 14,871 | +38.4% | 0.00% | 0.0% |
| Q4 2021 | $89,000 | -53.4% | 10,744 | -60.9% | 0.00% | -62.5% |
| Q3 2021 | $191,000 | – | 27,492 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $129,455,452 | 4.13% |
| Eversept Partners, LP | 2,200,999 | $12,325,594 | 1.08% |
| Kynam Capital Management, LP | 776,662 | $4,349,307 | 0.67% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 374,422 | $2,096,763 | 0.60% |
| Lion Point Capital, LP | 596,803 | $3,109,000 | 0.44% |
| Knott David M Jr | 200,100 | $1,121 | 0.42% |
| FEDERATED HERMES, INC. | 18,085,938 | $101,281,253 | 0.28% |
| Atom Investors LP | 95,520 | $534,912 | 0.27% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 20,200 | $113,120 | 0.09% |
| HARBOURVEST PARTNERS LLC | 49,363 | $276,433 | 0.09% |